Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10

Reporting Person: SATO VICKI L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-10	Stock Option (Right to Buy)	$20.00	A	22222	Acquired	2029-10-10	Common Stock (22222)	Direct

Footnotes

F1: 1/3 of the shares subject to the stock option vest and become exercisable on October 10, 2020, and the remainder vest in 24 equal monthly installments thereafter.